Dr. Sumit Isharwal, MD

Dr. Isharwal practices at Baptist MD Anderson Cancer Physicians in Jacksonville, Florida.

Dr. Isharwal's NPI, 1538455191, was assigned on June 22, 2011. Dr. Isharwal graduated from All India Institute of Medical Sciences in 2006. Dr. Isharwal holds Florida license ME1644485.

Dr. Isharwal's primary practice is Baptist MD Anderson Cancer Physicians, at 1301 Palm Ave, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-7300.

Dr. Isharwal's primary practice is Baptist MD Anderson Cancer Physicians in Jacksonville, Florida. Dr. Isharwal is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Isharwal to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Isharwal practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Isharwal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Isharwal is board certified in urology by the American Board of Urology. Dmand AI has Dr. Isharwal's licenses on file in 3 states: Florida, Virginia and New York.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, prostate inflammation or infection and prostate surgery among the conditions Dr. Isharwal treats.

CMS data shows 159 Medicare services from Dr. Isharwal across 8 procedure codes in 2024, for 138 Medicare patients. Medicare paid $9,762 for them.

CMS counts 138 Medicare patients who saw Dr. Isharwal in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high cholesterol, and 70% have cancer. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Isharwal's median patient age at 72, with 24% women.

In 2024, Dr. Isharwal wrote 90 Medicare Part D claims for 44 patients. 98% of them were for generic drugs. CMS names the drug for 43 of them, across 1 drug with 11 or more claims each, at $874 in total drug cost. In 2023, CMS named 109 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Isharwal for performance year 2024, reported as part of a group. Dr. Isharwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Isharwal as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Isharwal, published from 2006 to 2024. 2023 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Biomarkers, Tumor and Prostate. Dr. Isharwal has published most often in Prostate. Dr. Isharwal's most frequent co-authors are Jonathan Ira Epstein, MD, Yasmeen Tandon, MD and Dean F. Bajorin, MD.

CMS Open Payments shows 31 general payments to Dr. Isharwal from 8 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 63% of the total. AngioDynamics, Inc. paid the most, $4,217.

Dr. Isharwal graduated from All India Institute of Medical Sciences in 2006.

Dr. Isharwal is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.